United Therapeutics to showcase innovations and insights in pulmonary hypertension at PVRI 2025
United Therapeutics Corporation a public benefit corporation, announced that five posters across its commercial and development portfolio in pulmonary hypertension (PH) will be presented at the Pulmonary Vascular… read more.
